US 2018/0362554 A1Published application

4,6-di-(o-thiophosphate)-inositol-1,2,3,5-tetra-o-sulfate for c. difficile infection

AssigneeETH Zurich

InventorsMattias IVARSSON, Jean-Christophe LEROUX, Bastien CASTAGNER

Life of this patent

Estimating the term…

Abstract

The present invention relates to inositol bisthiophosphates-tetrakissulfates, particularly for use in treating symptoms associated with Clostridium difficile infection.

Claims8

Dependent claims

A compound characterized by the general formula (I)

wherein two out of six X are OPSO22− and the remaining X are OSO3−.

Dependencies are inferred from the claim text.

Facts

Application: 16/060,972Filed 12 Dec 2016
Priority: EP 15199681.611 Dec 2015
Published: 20 Dec 2018
Term ends: Not estimatedThe source records don’t support an estimate.

Classification4 codes

C07F 9/177
Esters of thiophosphoric acids: with cycloaliphatic alcohols
A61P 31/04
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics: antibacterial agents
C07F
Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen
A61P
Therapeutic uses of medicines

Family

US 10,487,097 B2Related patent
US 2018/0362554 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results